ArticleThe Clinical journal of pain2025
Impact of Pain Self-Efficacy on Health Outcomes in High-Impact Chronic Pain: A Longitudinal Study.
Article in The Clinical journal of pain, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pain Catastrophizing, Pain Self-Efficacy, and their Interaction as Predictors of Health Outcomes in Chronic Pain.medRxiv : the preprint server for health sciences · 2026Article
- The reliability and validity of the Turkish version of the University of Washington pain-related self-efficacy scale in patients with chronic low back and neck pain.BMC musculoskeletal disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesHigh-impact chronic pain (HICP), affecting 36.4% of individuals with chronic pain, significantly limits work, social, and self-care activities. Effective treatments for HICP remain elusive. In addition to pain catastrophizing (PC), growing evidence suggests that pain self-efficacy (PSE) may be a treatment target for HICP. Our study examines the relative contributions of pain self-efficacy and catastrophizing to health outcomes in patients with HICP.
methodsA total of 259 patients with chronic pain (154 with HICP; 105 without HICP) completed validated measures at baseline and 3 months later. These included the Chronic Pain Self-Efficacy Scale (CPSS), the Pain Catastrophizing Scale (PCS), and Patient-Reported Outcomes Measurement Information System (PROMIS) domains for physical health (ie, pain interference, physical function, fatigue, and sleep disturbance) and psychosocial health (ie, depression, anxiety, anger, and social isolation).
resultsRepeated measures MANOVA showed a significant group effect (HICP vs. No-HICP), but no significant time or group by time interaction. The HICP group reported significantly lower CPSS scores and higher PCS scores than the No-HICP group, alongside worse physical and psychosocial health outcomes (η²=0.076 to 0.445). PSE explained a greater proportion of group differences in health outcomes (52.9% to 71.7%) compared with PC (10.1% to 43.3%). Especially, SE in activity engagement accounted for the largest health disparities between the groups. DISCUSSION: Findings highlight PSE as a critical treatment target for HICP, with greater predictive utility than PC. Enhancing SE through tailored interventions may reduce the burden of HICP. Future studies should prioritize SE-based interventions and explore their scalability and long-term impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.